Showing results (361-370 of 374) with videos related to
Sort By:
Pageof 38
Molecular Psychiatry|January 4, 2012
Amine oxidase activity of β-amyloid precursor protein modulates systemic and local catecholamine levelsJ A Duce, S Ayton, A A Miller, et al.Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|February 24, 2001
Persistent symptoms among survivors of Hodgkin's disease: an explanatory model based on classical conditioningC L Cameron, D Cella, J E Herndon, et al.Thoracic Cancer|March 20, 2025
An Innovative Management in the Diagnosis of Mediastinal MassesG Messina, D G Pica, G Vicario, et al.Reproduction (Cambridge, England)|November 28, 2006
Relationships between sperm DNA fragmentation, sperm apoptotic markers and serum levels of CB-153 and p,p'-DDE in European and Inuit populationsA Stronati, G C Manicardi, M Cecati, et al.Neurourology and Urodynamics|April 18, 2024
A prospective study to assess the effectiveness and safety of the BlueWind System in the treatment of patients diagnosed with urgency urinary incontinenceJohn P F A Heesakkers, Philip Toozs-Hobson, Suzette E Sutherland, et al.Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitorsD A Campbell, X Y Xiao, D Harris, et al.Journal of Medicinal Chemistry|November 7, 1998
Substituted tetrahydropyrrolo[2,1-b]oxazol-5(6H)-ones and tetrahydropyrrolo[2,1-b]thiazol-5(6H)-ones as hypoglycemic agentsT D Aicher, B Balkan, P A Bell, et al.Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|March 28, 2014
[Hemodiafiltration with endogenous reinfusion in chronic inflammation: a possible therapeutic alternative?]Silvio Borrelli, W De Simone, B Zito, et al.The Journal of Urology|November 25, 2024
Two-Year Efficacy and Safety Outcomes of the Pivotal OASIS Study Using the Revi System for Treatment of Urgency Urinary IncontinenceJohn P F A Heesakkers, Philip Toozs-Hobson, Suzette E Sutherland, et al.Neurology|December 14, 2005
Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALSK L Ferrante, J Shefner, H Zhang, et al.Pageof 38